Skip to main content
. 2023 May 17;14:1148209. doi: 10.3389/fimmu.2023.1148209

Figure 12.

Figure 12

Use of GLP-1 Exendin-4 results in a) normalizes CRP levels in serum and medium b) low levels of MMP-9 and low MMP-9/TIMP ratios in serum and medium. (A) Data represent the mean ± SEM. *P<.05; **P<0.001, (B) Data represent the mean ± SEM. *P<.05; **P<0.01; ***P< 0.001 (182). Figure modified from article 183. Figure from Open access (European journal of pharmacology) permissible to re-use under a CC-BY 4.0 license).